Article and Video CATEGORIES

Cancer Journey

Search By

ABOUT
Denise Brock

Denise has over 30 years of varying experience in the healthcare arena.  In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees.  She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.  

 

Apply Now! Be a Part of the Clinical Trials Experiences Through Storytelling - Patient Perspectives 2023-24 Program
Fri, 05/19/2023 - 11:08
Applications are now open to be a part of the 2023-24 Patient Perspectives Program - Clinical Trials Experiences Through Storytelling
Author
Denise Brock
Image
Tell your story!  Apply now for the Clinical Trials Experiences through Storytelling Program
We are excited to launch our third year of this program; tell your story and help us help others!

Apply Online Now!

 


 

GRACE Patient Perspectives: Clinical Trials Experiences Storytelling Program Overview

 

The goal of this Patient Perspectives program is to give a voice to those who have experience in participating in a clinical trial for a cancer diagnosis.  By telling your story, you can educate others on the process, discuss your difficulties and share your accomplishments.  Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. 
 

Storytelling will take the form of written, video and/or audio/podcast to reach the largest audience.  GRACE staff will coach and support participants on digital outreach and advocacy. 

 

All people currently enrolled in, or with past enrollment in, a clinical trial for a cancer diagnosis are welcome and encouraged to apply. GRACE’s designated committee will review the nominees and select up to 3 applicants for participation in the 2023-24 program.

 

Who is GRACE?

 

The Global Resource for Advancing Cancer Education (GRACE, cancerGRACE.org) is a non-profit organization founded by leading Thoracic Oncologist, Dr. Howard (Jack) West, in 2007.  GRACE’s mission is to provide expert-mediated information directly to people with a cancer diagnosis and their caregivers to empower them to become direct partners in their cancer treatment.  We currently produce over 300 short videos each year, reaching our community in over 190 countries. 

 

Benefits of Participation

 

Applicants selected for this year’s program will work closely with GRACE staff to develop new educational content and learn new communication skills through the storytelling process.
Participants will receive training on digitally distributed content, social media and other platforms.  Participants work will be highlighted and shared by GRACE, our network of established leaders in the oncology community, and GRACE board members with an array of interests and connections.    

Participants will receive a stipend, training in communication and media platforms, and a tech ‘package’.  

 

Expectations

 

Participants will work with GRACE to develop program formats and production and will present a proposal based on their experience in a clinical trial program.  Participants will be expected to attend (via ZOOM) regular monthly meetings through the program year to learn and to discuss their ideas. A minimum of three (3) media productions per participant will be expected by the end of the program.  
 

Ideal Candidates

 

People who are navigating a cancer diagnosis, who are currently or have been involved in a clinical trial, and who have a passion for helping others and telling their story are ideal for this program.  

 

Applicants should have a particular interest and passion for communications, sharing experiences, storytelling, and patient education.  People looking for a way to give back to the cancer community, who exhibit strong written and oral communication skills coupled with a passion for sharing experiences in order to educate and advocate will thrive in this program.   GRACE will guide them through boosting their voice to advocate for themselves and others in the cancer community.     

 

2023 is our third year for this program, and we are excited to continue to generate a platform for patient advocacy and sharing patient education in the area of clinical trials.  
 

All application forms must be submitted by July 1, 2023 for consideration. Applicants will be contacted by August 1, 2023 with information regarding acceptance and the next steps.

To apply online please click here OR download the above attached pdf form and email it to dbrock@cancerGRACE.org.


Any questions, please contact Denise Brock at dbrock@cancergrace.org or 888-501-1025 x2.
 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Mandarin LCVL
Video
王林医生用普通话讨论重要的肺癌信息。这些信息包括靶向治疗、晚期疾病的症状、循环肿瘤 DNA、治疗方案等。我们鼓励您与社区中说普通话的人分享。 Dr. Lin Wang discusses important lung cancer information in Mandarin. This information includes targeted therapy, symptoms of advanced disease, circulating tumor DNA, treatment options, and more. We encourage you to share this with the Mandarin speakers in your community. To watch the complete Playlist visit: https://www.youtube.com/playlist?list=PLWsyUmdjLXhGnSxobmz4CBP3pxAj7nDa…;  
Image
Blood Cancer OncTalk
Video
Blood Cancer OncTalk was a live presentation that brought together top oncologists to discuss emerging concepts and treatment options in blood cancer. The program was chaired by Dr. Aaron Goodman, with the participation of Dr. Mazie Tsang, Hematologist / Oncologist; Dr. Autumn Jeong, Hematologist / Oncologist; Dr. Shaji Kumar, Hematologist / Oncologist; and Dr. Sridevi Rajeeve, Hematologist / Oncologist.
Image
Case Based Panel Discussions 2022
Video
Drs. Ibiayi Dagogo-Jack, Joshua Reuss, Natalie Vokes, and Kathryn Arbour discuss three hypothetical cases of suspected cancer, from staging to treatment options, with the goal of giving an insider look into the diagnostic side of lung cancer.  

Forum Discussions

Hi Caregiver and welcome to Grace.  I'm sorry that you need to be here and hope we can help.  Osimertinib has better efficacy than gefitinib (including OS and reaching the brain)...

Hi Bob, Welcome to Grace.  I'm sorry about your sil.  Unfortunately, cancer becomes resistant to TKIs like tagrisso.  Sometimes all of the cancer becomes resistant at once and sometimes just parts...

Recent Comments

JOIN THE CONVERSATION
Hi Tammy,  Welome to Grace. …
By JanineT GRACE … on Tue, 05/16/2023 - 13:44
Concerned
By Tndiuka10 on Fri, 05/12/2023 - 21:13
Hi Caregiver and welcome to…
By JanineT GRACE … on Fri, 05/12/2023 - 14:20
Hi Bob, Welcome to Grace.  I…
By JanineT GRACE … on Tue, 05/02/2023 - 12:29